Literature DB >> 24034617

Intraluminal containment of commensal outgrowth in the gut during infection-induced dysbiosis.

Michael J Molloy1, John R Grainger, Nicolas Bouladoux, Timothy W Hand, Lily Y Koo, Shruti Naik, Mariam Quinones, Amiran K Dzutsev, Ji-Liang Gao, Giorgio Trinchieri, Philip M Murphy, Yasmine Belkaid.   

Abstract

Shifts in commensal microbiota composition are emerging as a hallmark of gastrointestinal inflammation. In particular, outgrowth of γ-proteobacteria has been linked to the etiology of inflammatory bowel disease and the pathologic consequences of infections. Here we show that following acute Toxoplasma gondii gastrointestinal infection of mice, control of commensal outgrowth is a highly coordinated process involving both the host response and microbial signals. Notably, neutrophil emigration to the intestinal lumen results in the generation of organized intraluminal structures that encapsulate commensals and limit their contact with the epithelium. Formation of these luminal casts depends on the high-affinity N-formyl peptide receptor, Fpr1. Consequently, after infection, mice deficient in Fpr1 display increased microbial translocation, poor commensal containment, and increased mortality. Altogether, our study describes a mechanism by which the host rapidly contains commensal pathobiont outgrowth during infection. Further, these results reveal Fpr1 as a major mediator of host commensal interaction during dysbiosis.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24034617      PMCID: PMC4806337          DOI: 10.1016/j.chom.2013.08.003

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  59 in total

Review 1.  Insights into inflammatory bowel disease using Toxoplasma gondii as an infectious trigger.

Authors:  Charlotte E Egan; Sara B Cohen; Eric Y Denkers
Journal:  Immunol Cell Biol       Date:  2011-11-08       Impact factor: 5.126

2.  Polymorphisms of the formylpeptide receptor gene (FPR1) and susceptibility to stomach cancer in 1531 consecutive autopsy cases.

Authors:  Tatsuro Otani; Shinobu Ikeda; Htay Lwin; Tomio Arai; Masaaki Muramatsu; Motoji Sawabe
Journal:  Biochem Biophys Res Commun       Date:  2011-01-07       Impact factor: 3.575

Review 3.  The role of bacteria and pattern-recognition receptors in Crohn's disease.

Authors:  Si Ming Man; Nadeem O Kaakoush; Hazel M Mitchell
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-02-08       Impact factor: 46.802

4.  Increased neutrophil receptors for and response to the proinflammatory bacterial peptide formyl-methionyl-leucyl-phenylalanine in Crohn's disease.

Authors:  P A Anton; S R Targan; F Shanahan
Journal:  Gastroenterology       Date:  1989-07       Impact factor: 22.682

5.  Intestinal inflammation targets cancer-inducing activity of the microbiota.

Authors:  Janelle C Arthur; Ernesto Perez-Chanona; Marcus Mühlbauer; Sarah Tomkovich; Joshua M Uronis; Ting-Jia Fan; Barry J Campbell; Turki Abujamel; Belgin Dogan; Arlin B Rogers; Jonathan M Rhodes; Alain Stintzi; Kenneth W Simpson; Jonathan J Hansen; Temitope O Keku; Anthony A Fodor; Christian Jobin
Journal:  Science       Date:  2012-08-16       Impact factor: 47.728

6.  The G-protein-coupled formylpeptide receptor FPR confers a more invasive phenotype on human glioblastoma cells.

Authors:  J Huang; K Chen; J Chen; W Gong; N M Dunlop; O M Z Howard; Y Gao; X-w Bian; J M Wang
Journal:  Br J Cancer       Date:  2010-03-02       Impact factor: 7.640

Review 7.  International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family.

Authors:  Richard D Ye; François Boulay; Ji Ming Wang; Claes Dahlgren; Craig Gerard; Marc Parmentier; Charles N Serhan; Philip M Murphy
Journal:  Pharmacol Rev       Date:  2009-06-04       Impact factor: 25.468

8.  Production of peptides inducing chemotaxis and lysosomal enzyme release in human neutrophils by intestinal bacteria in vitro and in vivo.

Authors:  V S Chadwick; D M Mellor; D B Myers; A C Selden; A Keshavarzian; M F Broom; C H Hobson
Journal:  Scand J Gastroenterol       Date:  1988-01       Impact factor: 2.423

9.  Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease.

Authors:  Ben Willing; Jonas Halfvarson; Johan Dicksved; Magnus Rosenquist; Gunnar Järnerot; Lars Engstrand; Curt Tysk; Janet K Jansson
Journal:  Inflamm Bowel Dis       Date:  2009-05       Impact factor: 5.325

10.  Neutrophil infiltration of the colon is independent of the FPR1 yet FPR1 deficient mice show differential susceptibilities to acute versus chronic induced colitis.

Authors:  Shukkur M Farooq; Andrew W Stadnyk
Journal:  Dig Dis Sci       Date:  2012-03-02       Impact factor: 3.199

View more
  65 in total

1.  Human neutrophil formyl peptide receptor phosphorylation and the mucosal inflammatory response.

Authors:  Giovanna Leoni; Jeannie Gripentrog; Connie Lord; Marcia Riesselman; Ronen Sumagin; Charles A Parkos; Asma Nusrat; Algirdas J Jesaitis
Journal:  J Leukoc Biol       Date:  2014-11-13       Impact factor: 4.962

Review 2.  New development in studies of formyl-peptide receptors: critical roles in host defense.

Authors:  Liangzhu Li; Keqiang Chen; Yi Xiang; Teizo Yoshimura; Shaobo Su; Jianwei Zhu; Xiu-wu Bian; Ji Ming Wang
Journal:  J Leukoc Biol       Date:  2015-12-23       Impact factor: 4.962

3.  Neutrophils Oppose Uterine Epithelial Carcinogenesis via Debridement of Hypoxic Tumor Cells.

Authors:  Adam Blaisdell; Amandine Crequer; Devin Columbus; Takiko Daikoku; Khush Mittal; Sudhansu K Dey; Adrian Erlebacher
Journal:  Cancer Cell       Date:  2015-12-14       Impact factor: 31.743

4.  IL-1R Regulates Disease Tolerance and Cachexia in Toxoplasma gondii Infection.

Authors:  Stephanie J Melchor; Claire M Saunders; Imani Sanders; Jessica A Hatter; Kari A Byrnes; Sheryl Coutermarsh-Ott; Sarah E Ewald
Journal:  J Immunol       Date:  2020-04-29       Impact factor: 5.422

Review 5.  The molecular biology and immune control of chronic Toxoplasma gondii infection.

Authors:  Xiao-Yu Zhao; Sarah E Ewald
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

Review 6.  Enemy attraction: bacterial agonists for leukocyte chemotaxis receptors.

Authors:  Dominik Alexander Bloes; Dorothee Kretschmer; Andreas Peschel
Journal:  Nat Rev Microbiol       Date:  2014-12-15       Impact factor: 60.633

Review 7.  Why related bacterial species bloom simultaneously in the gut: principles underlying the 'Like will to like' concept.

Authors:  Sebastian E Winter; Andreas J Bäumler
Journal:  Cell Microbiol       Date:  2013-12-16       Impact factor: 3.715

8.  Interleukin-23 promotes intestinal T helper type17 immunity and ameliorates obesity-associated metabolic syndrome in a murine high-fat diet model.

Authors:  Larissa M S Martins; Malena M Perez; Camila A Pereira; Frederico R C Costa; Murilo S Dias; Rita C Tostes; Simone G Ramos; Marcel R de Zoete; Bernhard Ryffel; João S Silva; Daniela Carlos
Journal:  Immunology       Date:  2018-05-02       Impact factor: 7.397

Review 9.  Linking the Microbiota, Chronic Disease, and the Immune System.

Authors:  Timothy W Hand; Ivan Vujkovic-Cvijin; Vanessa K Ridaura; Yasmine Belkaid
Journal:  Trends Endocrinol Metab       Date:  2016-09-10       Impact factor: 12.015

Review 10.  T cells and intestinal commensal bacteria--ignorance, rejection, and acceptance.

Authors:  Jiani N Chai; You W Zhou; Chyi-Song Hsieh
Journal:  FEBS Lett       Date:  2014-07-02       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.